Q1 2018 Holdings
Filed 2018-05-15 | 118 holdings | $254.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Insulet Corp(PODD) | COM | 45784P101 | $14.8K | 171,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $15.8K | 1,213,181 | 0.0% |
| Menlo Therapeutics Inc | COM | 586858102 | $16.0K | 426,749 | 0.0% |
| Portola Pharmaceuticals IncCall | COM | 737010108 | $16.3K | 500,000 | 0.0% |
| Portola Pharmaceuticals IncPut | COM | 737010108 | $16.3K | 500,000 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $16.5K | 1,268,945 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $17.1K | 960,970 | 0.0% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $18.0K | 1,444,000 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $21.1K | 150,000 | 0.0% |
| Radius Health Inc | NOTE 3.000% 9/0 | 750469AA6 | $21.1K | $21,000,000 | 0.0% |
| AAC Hldgs Inc(AACH) | COM | 000307108 | $21.3K | 1,853,998 | 0.0% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $21.4K | 830,605 | 0.0% |
| Depomed Inc | NOTE 2.500% 9/0 | 249908AA2 | $22.0K | $27,019,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $22.4K | 869,000 | 0.0% |
| Aimmune Therapeutics Inc(AIMT) | COM | 00900T107 | $22.6K | 710,210 | 0.0% |
| Melinta Therapeutics Inc | COM | 58549G100 | $23.1K | 3,127,846 | 0.0% |
| Walgreens Boots Alliance Inc(WBA) | COM | 931427108 | $23.3K | 356,000 | 0.0% |
| K2m Group Hldgs Inc | NOTE 4.125% 8/1 | 48273JAB3 | $23.4K | $20,000,000 | 0.0% |
| Endocyte Inc | COM | 29269A102 | $23.9K | 2,627,540 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $24.0K | 615,000 | 0.0% |
| DFB Healthcare Acquistion Co | UNIT 01/30/2023 | 23291E208 | $25.1K | 2,500,000 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $25.4K | 225,452 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $26.3K | 484,055 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $26.5K | 882,462 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $27.5K | 697,194 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $27.6K | 3,788,540 | 0.0% |
| Aetna Inc New | COM | 00817Y108 | $27.9K | 165,000 | 0.0% |
| Intercept Pharmaceuticals in | NOTE 3.250% 7/0 | 45845PAA6 | $28.6K | $36,000,000 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $29.5K | 3,180,000 | 0.0% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $31.0K | 262,000 | 0.0% |
| Nevro Corp | NOTE 1.750% 6/0 | 64157FAA1 | $31.3K | $27,600,000 | 0.0% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $31.6K | 810,000 | 0.0% |
| Select MED Hldgs Corp(SEM) | COM | 81619Q105 | $32.1K | 1,858,000 | 0.0% |
| Davita Inc(DVA) | COM | 23918K108 | $32.1K | 486,427 | 0.0% |
| Intersect ENT Inc | COM | 46071F103 | $32.7K | 832,500 | 0.0% |
| CVS Health Corp(CVS) | COM | 126650100 | $34.2K | 550,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $34.8K | 378,950 | 0.0% |
| Endologix Inc | NOTE 3.250%11/0 | 29266SAB2 | $34.9K | $40,500,000 | 0.0% |
| CVS Health Corp(CVS)Call | COM | 126650100 | $35.3K | 566,800 | 0.0% |
| Wright MED Group N V | NOTE 2.250%11/1 | 98236JAB4 | $35.8K | $31,500,000 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $38.4K | 1,158,841 | 0.0% |
| Trinity Biotech Invt LTD | NOTE 4.000% 4/0 | 89643QAB4 | $38.6K | $48,000,000 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $41.6K | 1,384,470 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $42.0K | 191,000 | 0.0% |
| Lannet Inc | COM | 516012101 | $44.0K | 2,741,077 | 0.0% |
| Isis Pharmaceuticals Inc del | NOTE 1.000%11/1 | 464337AJ3 | $45.3K | $45,700,000 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $48.1K | 649,000 | 0.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $50.7K | 1,643,031 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $52.2K | 1,068,680 | 0.0% |
| Kempharm Inc | NOTE 5.500% 2/0 | 488445AB3 | $57.3K | $75,000,000 | 0.0% |